Personalized medicine eliminates need for drug in 2 children
from Bioscience Technology
Using genome-wide analysis, investigators have potentially eliminated a lifetime drug prescription that two children with a previously unknown type of adrenal insufficiency had been receiving for 14 years. Over a lifespan, the adjustment in treatment represents an approximate saving of $10,000 in drug and test costs per patient. Moreover, the less invasive treatment regime can potentially reduce the lifetime risk of hypertension in the patients.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063